Editorial | A swift and firm response is needed over Hong Kong vaccine scare

  • Concerns over BioNTech must be nipped in the bud, and the onus falls on the companies providing the jabs and the governments that approve them

A sign tells visitors to a Hong Kong vaccination centre that BioNTech jabs are on hold. Photo: May Tse

Vaccine scares are not uncommon. The abrupt suspension of Covid-19 shots made by BioNTech pending investigations over “packaging defects” in a batch administered in Hong Kong and Macau has put the governments’ emergency response to the test.

Until there is scientific evidence showing safety is compromised, the moratorium, officials say, is a case for precaution rather than alarm. That said, the fiasco does nothing for a campaign that is resisted by many people. Every effort must be made to reassure confidence.

Print option is available for subscribers only.
SUBSCRIBE NOW
Copyright © 2025 South China Morning Post Publishers Ltd. All rights reserved.